Skip to Main Content

Paper Details

Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiome.
Genome Med
7
2022
16S ribosomal RNA, 16S ribosomal RNA gene, CD, Cecal and sigmoid dysbiosis, Crohn's, Crohn's disease, Escherichia, Faecalibacterium, Fusobacterium, MLI, Obesity, cholate, deoxycholate, obese, obesity, patients
Author NameAffiliation
Jonathan P JacobsDavid Geffen School of Medicine at university of california los angeles
Jonathan P JacobsVeterans Administration Greater Los Angeles Healthcare System
Jonathan P JacobsDavid Geffen School of Medicine at university of california los angeles
Jonathan P JacobsVeterans Administration Greater Los Angeles Healthcare System
Maomeng TongDavid Geffen School of Medicine at university of california los angeles
Talin HarituniansF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Phillip FleshnerF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Gil Y MelmedF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Albert J FornaceGeorgetown University
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Jonathan BraunF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Jonathan BraunF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
  • 1 - 13

Datasets

Release 1.2